AASLD 2024 | Nadege Pelletier: Exploring new hope for innovative immunotherapy for chronic hepatitis B
Editor's note: Chronic hepatitis B (CHB) is a major public health problem worldwide. Although traditional antiviral drugs can inhibit viral replication to some extent, they are still inadequate in achieving…